Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 1Lymphoma, AIDS-Related 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 18Vincristine 15Zidovudine 11Bleomycin 11Cyclophosphamide 9Etoposide 8Interferon alpha-2 6Prednisone 5Cytarabine 5tecogalan 4sargramostim 4Rituximab 4Polymerase Chain Reaction 4Liposomes 4Filgrastim 4Dexamethasone 4Methotrexate 3Leucovorin 3Fluorouracil 3interferon alfa-n1 2Watchful Waiting 2Vinblastine 2Tumor Necrosis Factor-alpha 2Thalidomide 2Semaxinib 2Ritonavir 2Peripheral Blood Stem Cell Transplantation 2Mitoxantrone 2Light Coagulation 2Isotretinoin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × HIV Infections × Mitoguazone × Clear all
NCT00002348 2020-12-19

A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma

Sanofi

Phase 2 Completed
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, AIDS-Related

Data powered by HemOnc (CC BY 4.0) Colophon âš¡